| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Patrice D. Cani | Q30505257 |
| P2093 | author name string | Amandine Everard | |
| P2860 | cites work | Intestinal microbiota as modulators of the immune system and neuroimmune system: impact on the host health and homeostasis | Q21284481 |
| Microbial ecology of the gastrointestinal tract | Q22255628 | ||
| Enterotypes of the human gut microbiome | Q24489818 | ||
| Gut microbiota and metabolic syndrome | Q24563886 | ||
| Linking long-term dietary patterns with gut microbial enterotypes | Q24609914 | ||
| A human gut microbial gene catalogue established by metagenomic sequencing | Q24618931 | ||
| Modulation of the gut microbiota by nutrients with prebiotic and probiotic properties | Q26823918 | ||
| The influence of the human microbiome and probiotics on cardiovascular health | Q26992191 | ||
| Fiber and prebiotics: mechanisms and health benefits | Q27014809 | ||
| Resistant starch: promise for improving human health | Q28301879 | ||
| Diet rapidly and reproducibly alters the human gut microbiome | Q29547454 | ||
| Metabolic endotoxemia initiates obesity and insulin resistance | Q29547720 | ||
| Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity | Q29615051 | ||
| Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice | Q29615055 | ||
| Richness of human gut microbiome correlates with metabolic markers | Q29617365 | ||
| Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability | Q29617378 | ||
| Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome | Q29617424 | ||
| Gut microbiota composition correlates with diet and health in the elderly | Q29617441 | ||
| TLR4 links innate immunity and fatty acid-induced insulin resistance | Q29617577 | ||
| Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium. | Q30962119 | ||
| Response of gut microbiota to fasting and hibernation in Syrian hamsters | Q33495950 | ||
| Myeloid differentiation factor 88 (MyD88)-deficiency increases risk of diabetes in mice | Q33687009 | ||
| Prebiotic effects of wheat arabinoxylan related to the increase in bifidobacteria, Roseburia and Bacteroides/Prevotella in diet-induced obese mice | Q33939768 | ||
| Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. | Q34006689 | ||
| Dietary intervention impact on gut microbial gene richness | Q34037982 | ||
| Propensity to high-fat diet-induced obesity in rats is associated with changes in the gut microbiota and gut inflammation | Q34085293 | ||
| Differential modulation by Akkermansia muciniphila and Faecalibacterium prausnitzii of host peripheral lipid metabolism and histone acetylation in mouse gut organoids. | Q34093446 | ||
| Culture-independent microbial community analysis reveals that inulin in the diet primarily affects previously unknown bacteria in the mouse cecum | Q34095415 | ||
| Gut microbiota is a key modulator of insulin resistance in TLR 2 knockout mice | Q34097751 | ||
| Microbiome of prebiotic-treated mice reveals novel targets involved in host response during obesity | Q34175068 | ||
| A core human microbiome as viewed through 16S rRNA sequence clusters | Q34311676 | ||
| Structural changes of gut microbiota during berberine-mediated prevention of obesity and insulin resistance in high-fat diet-fed rats | Q34374252 | ||
| High fat diet-induced gut microbiota exacerbates inflammation and obesity in mice via the TLR4 signaling pathway | Q34455345 | ||
| Absence of intestinal microbiota does not protect mice from diet-induced obesity. | Q51401205 | ||
| C3H/HeJ mice carrying a toll-like receptor 4 mutation are protected against the development of insulin resistance in white adipose tissue in response to a high-fat diet | Q58106596 | ||
| A high-fat meal induces low-grade endotoxemia: evidence of a novel mechanism of postprandial inflammation | Q60998567 | ||
| Emulsified lipids increase endotoxemia: possible role in early postprandial low-grade inflammation | Q83372518 | ||
| Microbial enterotypes, inferred by the prevotella-to-bacteroides ratio, remained stable during a 6-month randomized controlled diet intervention with the new nordic diet | Q37545821 | ||
| Dietary-resistant starch and glucose metabolism | Q38003278 | ||
| Novel opportunities for next-generation probiotics targeting metabolic syndrome. | Q38275298 | ||
| The immunity-diet-microbiota axis in the development of metabolic syndrome | Q38360011 | ||
| Akkermansia muciniphila Adheres to Enterocytes and Strengthens the Integrity of the Epithelial Cell Layer. | Q38896866 | ||
| Dietary cocoa reduces metabolic endotoxemia and adipose tissue inflammation in high-fat fed mice | Q39956818 | ||
| EFFECT OF HIGH FAT DIETS ON INTESTINAL MICROFLORA AND SERUM CHOLESTEROL IN RATS. | Q40437868 | ||
| Influence of diets high and low in animal fat on bowel habit, gastrointestinal transit time, fecal microflora, bile acid, and fat excretion | Q40692202 | ||
| Juglone prevents metabolic endotoxemia-induced hepatitis and neuroinflammation via suppressing TLR4/NF-κB signaling pathway in high-fat diet rats | Q41240046 | ||
| Responses of gut microbiota to diet composition and weight loss in lean and obese mice | Q41816437 | ||
| Regulation of obesity-related insulin resistance with gut anti-inflammatory agents | Q42174194 | ||
| Absence of Tlr2 protects against high-fat diet-induced inflammation and results in greater insulin-stimulated glucose transport in cultured adipocytes | Q42470952 | ||
| A role for adipocyte-derived lipopolysaccharide-binding protein in inflammation- and obesity-associated adipose tissue dysfunction | Q42814704 | ||
| Effect of dietary fat and fiber on fecal flora, bacterial metabolites, and fecal properties in Japanese volunteers | Q43469858 | ||
| The intestinal microbiota in aged mice is modulated by dietary resistant starch and correlated with improvements in host responses | Q45384271 | ||
| Energy intake is associated with endotoxemia in apparently healthy men. | Q45769895 | ||
| A polyphenol-rich cranberry extract protects from diet-induced obesity, insulin resistance and intestinal inflammation in association with increased Akkermansia spp. population in the gut microbiota of mice. | Q46858371 | ||
| Alterations of the gut microbiota in high-fat diet mice is strongly linked to oxidative stress | Q48046587 | ||
| Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology | Q34481919 | ||
| Endotoxemia is associated with an increased risk of incident diabetes | Q34507178 | ||
| Stability of gut enterotypes in Korean monozygotic twins and their association with biomarkers and diet | Q34648507 | ||
| Intestinal epithelial MyD88 is a sensor switching host metabolism towards obesity according to nutritional status | Q34720051 | ||
| Toll-like receptor 4 knockout mice are protected against endoplasmic reticulum stress induced by a high-fat diet | Q34761132 | ||
| An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice | Q34785134 | ||
| Human intestinal metagenomics: state of the art and future | Q34841232 | ||
| Gut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: novel insights into molecular targets and interventions using prebiotics. | Q34866320 | ||
| Diet dominates host genotype in shaping the murine gut microbiota | Q34978394 | ||
| High-fat diet alters gut microbiota physiology in mice | Q34986213 | ||
| The gut microbiome modulates colon tumorigenesis | Q35032207 | ||
| Manipulating the gut microbiota to maintain health and treat disease | Q35044588 | ||
| Diversity in gut bacterial community of school-age children in Asia | Q35109207 | ||
| Bacterial endotoxin activity in human serum is associated with dyslipidemia, insulin resistance, obesity, and chronic inflammation | Q35123469 | ||
| An integrated catalog of reference genes in the human gut microbiome | Q35201849 | ||
| Intestinal microbiota in metabolic diseases: from bacterial community structure and functions to species of pathophysiological relevance | Q35202957 | ||
| Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice | Q35405358 | ||
| Comparative metabolomics in vegans and omnivores reveal constraints on diet-dependent gut microbiota metabolite production. | Q35458175 | ||
| Insights into the role of the microbiome in obesity and type 2 diabetes | Q35533602 | ||
| Conjugated Linoleic Acid Supplementation under a High-Fat Diet Modulates Stomach Protein Expression and Intestinal Microbiota in Adult Mice | Q35542798 | ||
| The influence of diet on the gut microbiota and its consequences for health | Q35548074 | ||
| Diet-induced obesity causes metabolic impairment independent of alterations in gut barrier integrity | Q35560150 | ||
| Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome | Q35570155 | ||
| Gut microbiota: a key player in health and disease. A review focused on obesity. | Q35573445 | ||
| Increased gut microbiota diversity and abundance of Faecalibacterium prausnitzii and Akkermansia after fasting: a pilot study | Q35575631 | ||
| Dysbiotic gut microbiota causes transmissible Crohn's disease-like ileitis independent of failure in antimicrobial defence. | Q35607473 | ||
| Gut metabolites and bacterial community networks during a pilot intervention study with flaxseeds in healthy adult men. | Q35635017 | ||
| Interactions between Diet, Bile Acid Metabolism, Gut Microbiota, and Inflammatory Bowel Diseases | Q35653374 | ||
| Metabolic adaptation to a high-fat diet is associated with a change in the gut microbiota | Q35799019 | ||
| Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-/- mice | Q36087089 | ||
| Intestinal alkaline phosphatase prevents metabolic syndrome in mice | Q36799117 | ||
| Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E | Q36986664 | ||
| Differential colonization with segmented filamentous bacteria and Lactobacillus murinus do not drive divergent development of diet-induced obesity in C57BL/6 mice | Q37173374 | ||
| High-fat diet determines the composition of the murine gut microbiome independently of obesity | Q37404989 | ||
| Flos Lonicera ameliorates obesity and associated endotoxemia in rats through modulation of gut permeability and intestinal microbiota | Q37514233 | ||
| P275 | copyright license | Creative Commons Attribution | Q6905323 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P921 | main subject | human digestive system | Q9649 |
| diet | Q474191 | ||
| environment | Q2249676 | ||
| physiological phenomenon | Q66615932 | ||
| P304 | page(s) | 58-66 | |
| P577 | publication date | 2015-07-16 | |
| 2016-01-01 | |||
| P1433 | published in | Molecular Nutrition and Food Research | Q15751861 |
| P1476 | title | Talking microbes: When gut bacteria interact with diet and host organs | |
| P478 | volume | 60 |
| Q92615877 | Abundance of Gut Microbiota, Concentration of Short-Chain Fatty Acids, and Inflammatory Markers Associated with Elevated Body Fat, Overweight, and Obesity in Female Adolescents |
| Q90457180 | Adipose tissue inflammation and metabolic syndrome. The proactive role of probiotics |
| Q36244324 | An Integrated View of the Effects of Wine Polyphenols and Their Relevant Metabolites on Gut and Host Health. |
| Q91788029 | Autoimmune liver disease and the enteric microbiome |
| Q98778639 | Brain-gut-microbiome interactions in obesity and food addiction |
| Q55112722 | Breath methane concentrations and markers of obesity in patients with functional gastrointestinal disorders. |
| Q41584110 | Cell-Surface and Nuclear Receptors in the Colon as Targets for Bacterial Metabolites and Its Relevance to Colon Health |
| Q47818880 | Complementary and Alternative Medicine Strategies for Therapeutic Gut Microbiota Modulation in Inflammatory Bowel Disease and their Next-Generation Approaches. |
| Q38824606 | Designing food delivery systems: challenges related to the in vitro methods employed to determine the fate of bioactives in the gut. |
| Q92537172 | Diet in Parkinson's Disease: Critical Role for the Microbiome |
| Q60923096 | Dietary Habits and Abdominal Pain-related Functional Gastrointestinal Disorders: A School-based, Cross-sectional Analysis in Greek Children and Adolescents |
| Q39042753 | Enterosalivary nitrate metabolism and the microbiome: Intersection of microbial metabolism, nitric oxide and diet in cardiac and pulmonary vascular health |
| Q39113167 | Evolutionary and ecological forces that shape the bacterial communities of the human gut. |
| Q39370710 | Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. |
| Q54954201 | Fecal Enterobacteriales enrichment is associated with increased in vivo intestinal permeability in humans. |
| Q90267087 | Feeding Infants Formula With Probiotics or Milk Fat Globule Membrane: A Double-Blind, Randomized Controlled Trial |
| Q39294902 | Food additives, contaminants and other minor components: effects on human gut microbiota-a review. |
| Q92800145 | Functional Effects of EPS-Producing Bifidobacterium Administration on Energy Metabolic Alterations of Diet-Induced Obese Mice |
| Q52839364 | Gut microbiome and liver diseases. |
| Q30224289 | Gut microbiota — at the intersection of everything? |
| Q40960577 | High-fat diet feeding differentially affects the development of inflammation in the central nervous system. |
| Q28077145 | How gut microbes talk to organs: The role of endocrine and nervous routes |
| Q30383536 | Immune-Microbiota Interactions: Dysbiosis as a Global Health Issue. |
| Q47140808 | In Vitro Fermentation Patterns of Rice Bran Components by Human Gut Microbiota |
| Q33838147 | Interactions between gut microbes and host cells control gut barrier and metabolism |
| Q28078741 | Microbiota-host interplay at the gut epithelial level, health and nutrition |
| Q52656992 | Mycotoxin: Its Impact on Gut Health and Microbiota. |
| Q41987488 | Next-Generation Beneficial Microbes: The Case of Akkermansia muciniphila |
| Q26745706 | Novel perspectives on therapeutic modulation of the gut microbiota |
| Q33805550 | Obesity and microbiota: an example of an intricate relationship. |
| Q55514036 | Probiotic Bifidobacterium strains and galactooligosaccharides improve intestinal barrier function in obese adults but show no synergism when used together as synbiotics. |
| Q38598371 | Probiotics and the Gut Immune System: Indirect Regulation |
| Q92588858 | Progress in Mycotoxins Affecting Intestinal Mucosal Barrier Function |
| Q47772002 | Recent Development of Prebiotic Research-Statement from an Expert Workshop |
| Q51278644 | Reduction in cardiometabolic risk factors by a multifunctional diet is mediated via several branches of metabolism as evidenced by nontargeted metabolite profiling approach. |
| Q61449581 | Regulation of Adaptive Thermogenesis and Browning by Prebiotics and Postbiotics |
| Q47923338 | Research Gaps in Diet and Nutrition in Inflammatory Bowel Disease. A Topical Review by D-ECCO Working Group [Dietitians of ECCO]. |
| Q58614694 | Resveratrol, Metabolic Syndrome, and Gut Microbiota |
| Q38811473 | SCFA Receptors in Pancreatic β Cells: Novel Diabetes Targets? |
| Q38743729 | The Gut Microbiome, Obesity, and Weight Control in Women's Reproductive Health |
| Q38829534 | Urolithins, the rescue of "old" metabolites to understand a "new" concept: Metabotypes as a nexus among phenolic metabolism, microbiota dysbiosis, and host health status |
Search more.